Clinical implications of myelin regeneration in the central nervous system

References

• Tasaki I. The electro-saltatory transmission of the nerve impulse and the effect of narcosis upon the nerve fiber. Am J Physiol. 1939;127:211–227.
   Google Scholar
• Pohl HBF, Porcheri C, Mueggler T, et al. Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage. J Neurosci. 2011;31:1069–1080.
   PubMed Web of Science ®Google Scholar
• Garbern JY, Yool DA, Moore GJ, et al. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain. 2002;125:551–561.
   PubMed Web of Science ®Google Scholar
• McDonald WI, Sears TA. Effect of demyelination on conduction in the central nervous system. Nature. 1969;221:182–183.
   PubMed Web of Science ®Google Scholar
• Griffiths I, Klugmann M, Anderson T, et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science. 1998;280:1610–1613.
   PubMed Web of Science ®Google Scholar
• Lee Y, Morrison BM, Li Y, et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature. 2012;487:443–448.
   PubMed Web of Science ®Google Scholar
• Tallantyre EC, Bø L, Al-Rawashdeh O, et al. Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis. Mult Scler. 2010;16:406–411.
   PubMed Web of Science ®Google Scholar
• Alonso A, Jick SS, Olek MJ, et al. Incidence of multiple sclerosis in the United Kingdom: findings from a population-based cohort. J Neurol. 2007;254:1736–1741.
   PubMed Web of Science ®Google Scholar
• Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15:545–558.
   PubMed Web of Science ®Google Scholar
• Komiyama Y, Nakae S, Matsuki T, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol. 2006;177:566–573.
   PubMed Web of Science ®Google Scholar
• Frischer JM, Bramow S, Dal-Bianco A, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009;132:1175–1189.
   PubMed Web of Science ®Google Scholar
• Coles AJ, Twyman CL, Arnold DL, et al. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial. Lancet. 2012;380:1829–1839.
   PubMed Web of Science ®Google Scholar
• Vellinga MM, Geurts JJG, Rostrup E, et al. Clinical correlations of brain lesion distribution in multiple sclerosis. J Magn Reson Imaging. 2009;29:768–773.
   PubMed Web of Science ®Google Scholar
• Kearney H, Altmann DR, Samson RS, et al. Cervical cord lesion load is associated with disability independently from atrophy in MS. Neurology. 2015;84:367–373.
   PubMed Web of Science ®Google Scholar
• Redford EJ, Kapoor R, Smith KJ. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain. 1997;120:2149–2157.
   PubMed Web of Science ®Google Scholar
• Waxman SG. Axonal conduction and injury in multiple sclerosis: the role of sodium channels. Nat Rev Neurosci. 2006;7:932–941.
   PubMed Web of Science ®Google Scholar
• Trapp BD, Nave K-A. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci. 2008;31:247–269.
   PubMed Web of Science ®Google Scholar
• Simon JH, Kleinschmidt-DeMasters BK. MR imaging in white matter diseases of the brain and spinal cord. Medical Radiology Diagnostic Imaging. Berlin/Heidelberg: Springer-Verlag; 2005
   Google Scholar
• Trebst C, Jarius S, Berthele A, et al. Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the neuromyelitis optica study group (NEMOS). J Neurol. 2014;261:1–16.
   PubMed Web of Science ®Google Scholar
• Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol. 2004; Neurosurgery & Psychiatry, 75: iii22–8.
   Web of Science ®Google Scholar
• Parkinson RB, Hopkins RO, Cleavinger HB, et al. White matter hyperintensities and neuropsychological outcome following carbon monoxide poisoning. Neurology. 2002;58:1525–1532.
   PubMed Web of Science ®Google Scholar
• Cammer W, Rose AL, Norton WT. Biochemical and pathological studies of myelin in hexachlorophene intoxication. Brain Res. 1975;98:547–559.
   PubMed Web of Science ®Google Scholar
• Miller A, Korem M, Almog R, et al. Vitamin B12, demyelination, remyelination and repair in multiple sclerosis. J Neurol Sci. 2005;233:93–97.
   PubMed Web of Science ®Google Scholar
• Ferenczy MW, Marshall LJ, Nelson CDS, et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 2012;25:471–506.
   PubMed Web of Science ®Google Scholar
• Steelman AJ. Infection as an environmental trigger of multiple sclerosis disease exacerbation. Front Immunol. 2015;6:1–13.
   PubMed Web of Science ®Google Scholar
• Medana IM, Esiri MM. Axonal damage: a key predictor of outcome in human CNS diseases. Brain. 2003;126:515–530.
   PubMed Web of Science ®Google Scholar
• Koeppen AH, Ronca NA, Greenfield EA, et al. Defective biosynthesis of proteolipid protein in pelizaeus-merzbacher disease. Ann Neurol. 1987;21:159–170.
   PubMed Web of Science ®Google Scholar
• Chrast R, Saher G, Nave K-A, et al. Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models. J Lipid Res. 2011;52:419–434.
   PubMed Web of Science ®Google Scholar
• Franklin RJ, Goldman SA. Glia disease and repair—remyelination. Cold Spring Harb Perspect Bio. 2015;7:a020594.
   PubMed Web of Science ®Google Scholar
• Brown JWL, Coles A, Horakova D, et al. The effect of disease-modifying therapies on conversion to secondary progressive multiple sclerosis. ECTRIMS Abstract. 2017
   Google Scholar
• Lee JY, Taghian K, Petratos S. Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability? Acta Neuropathol Commun. 2014;2:97.
   PubMed Web of Science ®Google Scholar
• Kiryu-Seo S, Ohno N, Kidd GJ, et al. Demyelination increases axonal stationary mitochondrial size and the speed of axonal mitochondrial transport. J Neurosci. 2010;30:6658–6666.
   PubMed Web of Science ®Google Scholar
• Craner MJ, Newcombe J, Black JA, et al. Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger. Proc Natl Acad Sci U S A. 2004;101:8168–8173.
   PubMed Web of Science ®Google Scholar
• Fünfschilling U, Supplie LM, Mahad D, et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature. 2012;485:517–521.
   PubMed Web of Science ®Google Scholar
• Franklin RJM, ffrench-Constant C. Regenerating CNS myelin — from mechanisms to experimental medicines. Nat Rev Neurosci. 2017;18:753–769.
   PubMed Web of Science ®Google Scholar
• Di Bello IC, Dawson MR, Levine JM, et al. Generation of oligodendroglial progenitors in acute inflammatory demyelinating lesions of the rat brain stem is associated with demyelination rather than inflammation. J Neurocytol. 1999;28:365–381.
   PubMedGoogle Scholar
• Crawford AH, Stockley JH, Tripathi RB, et al. Oligodendrocyte progenitors: adult stem cells of the central nervous system? Exp Neurol. 2014;260:50–55.
   PubMed Web of Science ®Google Scholar
• Zawadzka M, Rivers LE, Fancy SPJ, et al. CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell. 2010;6:578–590.
   PubMed Web of Science ®Google Scholar
• Smith KJ, Blakemore WF, McDonald WI. Central remyelination restores secure conduction. Nature. 1979;280:395–396.
   PubMed Web of Science ®Google Scholar
• Duncan ID, Brower A, Kondo Y, et al. Extensive remyelination of the CNS leads to functional recovery. Proc Natl Acad Sci. 2009;106:6832–6836.
   PubMed Web of Science ®Google Scholar
• Irvine KA, Blakemore WF. Remyelination protects axons from demyelination-associated axon degeneration. Brain. 2008;131:1464–1477.
   PubMed Web of Science ®Google Scholar
• Young KM, Psachoulia K, Tripathi RB, et al. Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling. Neuron. 2013;77:873–885.
   PubMed Web of Science ®Google Scholar
• Itoyama Y, Webster HD, Richardson EP, et al. Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions. Ann Neurol. 1983;14:339–346.
   PubMed Web of Science ®Google Scholar
• Blakemore WF. Remyelination by Schwann cells of axons demyelinated by intraspinal injection of 6-aminonicotinamide in the rat. J Neurocytol. 1975;4:745–757.
   PubMedGoogle Scholar
• Franklin RJ, Blakemore WF. Requirements for schwann cell migration within CNS environments: a viewpoint. Int J Dev Neurosci. 1993;11:641–649.
   PubMed Web of Science ®Google Scholar
• Duncan ID, Hoffman RL. Schwann cell invasion of the central nervous system of the myelin mutants. J Anat. 1997;190:35–49.
   PubMed Web of Science ®Google Scholar
• Patrikios P, Stadelmann C, Kutzelnigg A, et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain. 2006;129:3165–3172.
   PubMed Web of Science ®Google Scholar
• Kornek B, Storch MK, Weissert R, et al. Multiple sclerosis and chronic autoimmune encephalomyelitis. Am J Pathol. 2000;157:267–276.
   PubMed Web of Science ®Google Scholar
• Schultz V, Van der Meer F, Wrzos C, et al. Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination. Glia. 2017;65:1350–1360.
   PubMed Web of Science ®Google Scholar
• Bodini B, Veronese M, García-Lorenzo D, et al. Dynamic imaging of individual remyelination profiles in multiple sclerosis. Ann Neurol. 2016;79:726–738.
   PubMed Web of Science ®Google Scholar
• Goldschmidt T, Antel J, König FB, et al. Remyelination capacity of the MS brain decreases with disease chronicity. Neurology. 2009;72:1914–1921.
   PubMed Web of Science ®Google Scholar
• Franklin RJM. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci. 2002;3:705–714.
   PubMed Web of Science ®Google Scholar
• Lucchinetti C, Brück W, Parisi J, et al. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain. 1999;122:2279–2295.
   PubMed Web of Science ®Google Scholar
• Boyd A, Zhang H, Williams A. Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models. Acta Neuropathol. 2013;125:841–859.
   PubMed Web of Science ®Google Scholar
• Shen S, Sandoval J, Swiss VA, et al. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat Neurosci. 2008;11:1024–1034.
   PubMed Web of Science ®Google Scholar
• Zhao C, Li -W-W, Franklin RJM. Differences in the early inflammatory responses to toxin-induced demyelination are associated with the age-related decline in CNS remyelination. Neurobiol Aging. 2006;27:1298–1307.
   PubMed Web of Science ®Google Scholar
• Confavreux C, Vukusic S. Age at disability milestones in multiple sclerosis. Brain. 2006;129:595–605.
   PubMed Web of Science ®Google Scholar
• Moyon S, Dubessy AL, Aigrot MS, et al. Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration. J Neurosci. 2015;35:4–20.
   PubMed Web of Science ®Google Scholar
• Fancy SPJ, Zhao C, Franklin RJM. Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol Cell Neurosci. 2004;27:247–254.
   PubMed Web of Science ®Google Scholar
• Zhao C, Ma D, Zawadzka M, et al. Sox2 sustains recruitment of oligodendrocyte progenitor cells following CNS demyelination and primes them for differentiation during remyelination. J Neurosci. 2015;35:11482–11499.
   PubMed Web of Science ®Google Scholar
• Hinks GL, Franklin RJM. Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-β1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Mol Cell Neurosci. 1999;14:153–168.
   PubMed Web of Science ®Google Scholar
• Woodruff RH, Fruttiger M, Richardson WD, et al. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol Cell Neurosci. 2004;25:252–262.
   PubMed Web of Science ®Google Scholar
• Piaton G, Aigrot MS, Williams A, et al. Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system. Brain. 2011;134:1156–1167.
   PubMed Web of Science ®Google Scholar
• Fancy SPJ, Harrington EP, Yuen TJ, et al. Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci. 2011;14:1009–1016.
   PubMed Web of Science ®Google Scholar
• Mi S, Miller RH, Lee X, et al. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci. 2005;8:745–751.
   PubMed Web of Science ®Google Scholar
• Mi S, Blake Pepinsky R, Cadavid D. Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinic. CNS Drugs. 2013;27:493–503.
   PubMed Web of Science ®Google Scholar
• Mi S, Miller RH, Tang W, et al. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol. 2009;65:304–315.
   PubMed Web of Science ®Google Scholar
• Mi S, Hu B, Hahm K, et al. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med. 2007;13:1228–1233.
   PubMed Web of Science ®Google Scholar
• Fancy SPJ, Baranzini SE, Zhao C, et al. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev. 2009;23:1571–1585.
   PubMed Web of Science ®Google Scholar
• Fancy SPJ, Harrington EP, Baranzini SE, et al. Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer. Nat Neurosci. 2014;17:506–512.
   PubMed Web of Science ®Google Scholar
• Barker N, Clevers H. Mining the Wnt pathway for cancer therapeutics. Nature Rev Drug Discov. 2006;5:997–1014.
   PubMed Web of Science ®Google Scholar
• Huang JK, Jarjour AA, Nait Oumesmar B, et al. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nature Neurosci. 2011;14:45–53.
   PubMed Web of Science ®Google Scholar
• Guzman De La Fuente A, Errea O, Wijngaarden PV, et al. Vitamin D receptor – retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation. J Biol. 2015;211:975–985.
   Google Scholar
• Altucci L, Leibowitz MD, Ogilvie KM, et al. RAR and RXR modulation in cancer and metabolic disease. Nat Rev Drug Discov. 2007;6:793–810.
   PubMed Web of Science ®Google Scholar
• Natrajan MS, De La Fuente AG, Crawford AH, et al. Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination. Brain. 2015;138:3581–3597.
   PubMed Web of Science ®Google Scholar
• Deshmukh VA, Tardif V, Lyssiotis CA, et al. A regenerative approach to the treatment of multiple sclerosis. Nature. 2013;502:327–332.
   PubMed Web of Science ®Google Scholar
• Najm FJ, Madhavan M, Zaremba A, et al. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature. 2015;522:216–220.
   PubMed Web of Science ®Google Scholar
• Mei F, Fancy SPJ, Shen Y-A-A, et al. Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis. Nature Med. 2014;20:954–960.
   PubMed Web of Science ®Google Scholar
• Mei F, Lehmann-Horn K, Shen Y-A-A, et al. Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery. eLife. 2016;5:1–21.
   Web of Science ®Google Scholar
• Green A, Gelfand J, Cree B, et al. Over-the-counter drug may reverse vision damage caused by multiple sclerosis. American Academy of Neurology 68th Annual Meeting Abstract. 2016
   Google Scholar
• Simons BD, Clevers H. Strategies for homeostatic stem cell self-renewal in adult tissues. Cell. 2011;145:851–862.
   PubMed Web of Science ®Google Scholar
• Rojas-Ríos P, González-Reyes A. Concise review: the plasticity of stem cell niches: a general property behind tissue homeostasis and repair. Stem Cells. 2014;32:852–859.
   PubMed Web of Science ®Google Scholar
• Miron VE, Franklin RJM. Macrophages and CNS remyelination. J Neurochem. 2014;130:165–171.
   PubMed Web of Science ®Google Scholar
• Robinson S, Miller RH. Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation. Dev Biol. 1999;216:359–368.
   PubMed Web of Science ®Google Scholar
• Kotter MR, Li -W-W, Zhao C, et al. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci. 2006;26:328–332.
   PubMed Web of Science ®Google Scholar
• Hinks GL, Franklin RJ. Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats. Mol Cell Neurosci. 2000;16:542–556.
   PubMed Web of Science ®Google Scholar
• Miron VE, Boyd A, Zhao J-W, et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci. 2013;16:1211–1218.
   PubMed Web of Science ®Google Scholar
• McMorris FA, Dubois-Dalcq M. Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro. J Neurosci Res. 1988;21:199–209.
   PubMed Web of Science ®Google Scholar
• McKinnon RD, Piras G, Ida JA, et al. A role for TGF-beta in oligodendrocyte differentiation. J Cell Biol. 1993;121:1397–1407.
   PubMed Web of Science ®Google Scholar
• Setzu A, Lathia JD, Zhao C, et al. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia. 2006;54:297–303.
   PubMed Web of Science ®Google Scholar
• Yuen TJ, Johnson KR, Miron VE, et al. Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination. Brain. 2013;136:1035–1047.
   PubMed Web of Science ®Google Scholar
• Ruckh JM, Zhao J-W, Shadrach JL, et al. Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell. 2012;10:96–103.
   PubMed Web of Science ®Google Scholar
• Dombrowski Y, O’Hagan T, Dittmer M, et al. Regulatory T cells promote myelin regeneration in the central nervous system. Nature Neurosci. 2017;20:674–680.
   PubMed Web of Science ®Google Scholar
• Kigerl KA, De Rivero Vaccari JP, Dietrich WD, et al. Pattern recognition receptors and central nervous system repair. Exp Neurol. 2014;258:5–16.
   PubMed Web of Science ®Google Scholar
• Williams A, Piaton G, Lubetzki C. Astrocytes - friends or foes in multiple sclerosis? Glia. 2007;55:1300–1312.
   PubMed Web of Science ®Google Scholar
• Moore CS, Milner R, Nishiyama A, et al. Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination. J Neurosci. 2011;31:6247–6254.
   PubMed Web of Science ®Google Scholar
• Monteiro De Castro G, Deja NA, Ma D, et al. Astrocyte activation via Stat3 signaling determines the balance of oligodendrocyte versus Schwann cell remyelination. Am J Pathol. 2015;185:2431–2440.
   PubMed Web of Science ®Google Scholar
• Lau LW, Cua R, Keough MB, et al. Pathophysiology of the brain extracellular matrix: a new target for remyelination. Nat Rev Neurosci. 2013;14:722–729.
   PubMed Web of Science ®Google Scholar
• Urbanski MM, Kingsbury L, Moussouros D, et al. Myelinating glia differentiation is regulated by extracellular matrix elasticity. Sci Rep. 2016;6:33751.
   PubMed Web of Science ®Google Scholar
• Lourenço T, Paes De Faria J, Bippes CA, et al. Modulation of oligodendrocyte differentiation and maturation by combined biochemical and mechanical cues. Sci Rep. 2016;6:21563.
   PubMed Web of Science ®Google Scholar
• Gibson EM, Purger D, Mount CW, et al. Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science. 2014;344:1252304.
   PubMed Web of Science ®Google Scholar
• Etxeberria A, Hokanson KC, Dao DQ, et al. Dynamic modulation of myelination in response to visual stimuli alters optic nerve conduction velocity. J Neurosci. 2016;36:6937–6948.
   PubMed Web of Science ®Google Scholar
• Gautier HOB, Evans KA, Volbracht K, et al. Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors. Nat Commun. 2015;6:8518.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang Y-P, Kirsner RS. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc Res Tech. 2003;60:107–114.
   PubMed Web of Science ®Google Scholar
• De La Fuente AG, Lange S, Silva ME, et al. Pericytes stimulate oligodendrocyte progenitor cell differentiation during CNS remyelination. Cell Rep. 2017;20:1755–1764.
   PubMed Web of Science ®Google Scholar
• Franklin RJM, ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci. 2008;9:839–855.
   PubMed Web of Science ®Google Scholar
• Windrem MS, Roy NS, Wang J, et al. Progenitor cells derived from the adult human subcortical white matter disperse and differentiate as oligodendrocytes within demyelinated lesions of the rat brain. J Neurosci Res. 2002;69:966–975.
   PubMed Web of Science ®Google Scholar
• Windrem MS, Nunes MC, Rashbaum WK, et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med. 2004;10:93–97.
   PubMed Web of Science ®Google Scholar
• Dietrich J, Noble M, Mayer-Proschel M. Characterization of A2B5+ glial precursor cells from cryopreserved human fetal brain progenitor cells. Glia. 2002;40:65–77.
   PubMed Web of Science ®Google Scholar
• Roy NS, Wang S, Harrison-Restelli C, et al. Identification, isolation, and promoter-defined separation of mitotic oligodendrocyte progenitor cells from the adult human subcortical white matter. J Neurosci. 1999;19:9986–9995.
   PubMed Web of Science ®Google Scholar
• Hu B-Y, Du Z-W, Zhang S-C. Differentiation of human oligodendrocytes from pluripotent stem cells. Nature Protoc. 2009;4:1614–1622.
   PubMed Web of Science ®Google Scholar
• Izrael M, Zhang P, Kaufman R, et al. Human oligodendrocytes derived from embryonic stem cells: effect of noggin on phenotypic differentiation in vitro and on myelination in vivo. Mol Cell Neurosci. 2007;34:310–323.
   PubMed Web of Science ®Google Scholar
• Wang S, Bates J, Li X, et al. Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell. 2013;12:252–264.
   PubMed Web of Science ®Google Scholar
• Ehrlich M, Mozafari S, Glatza M, et al. Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors. Proc Natl Acad Sci. 2017;114:E2243–E2252.
   PubMed Web of Science ®Google Scholar
• Najm FJ, Lager AM, Zaremba A, et al. Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells. Nature Biotechnol. 2013;31:426–433.
   PubMed Web of Science ®Google Scholar
• Goldman SA, Nedergaard M, Windrem MS. Glial progenitor cell based treatment and modeling of neurological disease. Science. 2012;338:491–495.
   PubMed Web of Science ®Google Scholar
• Goldman SA. White matter from fibroblasts. Nature Biotechnol. 2013;31:412–413.
   PubMed Web of Science ®Google Scholar
• Nistor GI, Totoiu MO, Haque N, et al. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia. 2005;49:385–396.
   PubMed Web of Science ®Google Scholar
• Roy NS, Cleren C, Singh SK, et al. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med. 2006;12:1259–1268.
   PubMed Web of Science ®Google Scholar
• Pruszak J, Ludwig W, Blak A, et al. CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells. Stem Cells. 2009;27:2928–2940.
   PubMed Web of Science ®Google Scholar
• Snyder EY, Taylor RM, Wolfe JH. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Mol Med Today. 1995;1:111.
   Google Scholar
• Urayama A, Grubb JH, Sly WS, et al. Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier. Proc Natl Acad Sci. 2004;101:12658–12663.
   PubMed Web of Science ®Google Scholar
• Lacorazza HD, Flax JD, Snyder EY, et al. Expression of human beta-hexosaminidase alpha-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells. Nat Med. 1996;2:424–429.
   PubMed Web of Science ®Google Scholar
• Jeyakumar M, Dwek RA, Butters TD, et al. Storage solutions: treating lysosomal disorders of the brain. Nat Rev Neurosci. 2005;6:713–725.
   PubMedGoogle Scholar
• Boucher AA, Miller W, Shanley R, et al. Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report. Orphanet J Rare Dis. 2015;10:94.
   PubMed Web of Science ®Google Scholar
• Biffi A, Lucchini G, Rovelli A, et al. Metachromatic leukodystrophy: an overview of current and prospective treatments. Bone Marrow Transplant. 2008;42:S2–S6.
   PubMed Web of Science ®Google Scholar
• Bunge M, Bunge R, Ris H. Ultrastructural study of remyelination in an experimental lesion in adult cat spinal cord. J Biophys Biochem Cytol. 1961;10:67–94.
   PubMedGoogle Scholar
• Gupta N, Henry RG, Strober J, et al. Neural stem cell engraftment and myelination in the human brain. Sci Transl Med. 2012;4:155ra137.
   PubMed Web of Science ®Google Scholar
• Osorio MJ, Rowitch DH, Tesar P, et al. Concise review: stem cell-based treatment of pelizaeus merzbacher disease. Stem Cells. 2017;35:311–315.
   PubMed Web of Science ®Google Scholar
• Bove RM, Green AJ. Remyelinating pharmacotherapies in multiple sclerosis. Neurotherapeutics 2017;14:894–904. Epub ahead of print.
   Google Scholar
• Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998;338:278–285.
   PubMed Web of Science ®Google Scholar
• Rivera-Quiñones C, McGavern D, Schmelzer JD, et al. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat Med. 1998;4:187–193.
   PubMed Web of Science ®Google Scholar
• Medana I, Martinic MA, Wekerle H, et al. Transection of major histocompatibility complex class i-induced neurites by cytotoxic T lymphocytes. Am J Pathol. 2001;159:809–815.
   PubMed Web of Science ®Google Scholar
• Nikić I, Merkler D, Sorbara C, et al. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med. 2011;17:495–499.
   PubMed Web of Science ®Google Scholar
• Ballanger F, Nguyen J, Khammari A, et al. Evolution of clinical and molecular responses to bexarotene treatment in cutaneous T-cell lymphoma. Dermatology. 2010;220:370–375.
   PubMed Web of Science ®Google Scholar
• Döring A, Sloka S, Lau L, et al. Stimulation of monocytes, macrophages, and microglia by amphotericin B and macrophage colony-stimulating factor promotes remyelination. J Neurosci. 2015;35:1136–1148.
   PubMed Web of Science ®Google Scholar
• Fralix TA, Ceckler TL, Wolff SD, et al. Lipid bilayer and water proton magnetization transfer: effect of cholesterol. Magn Reson Med. 1991;18:214–223.
   PubMed Web of Science ®Google Scholar
• Deloire-Grassin MS, Brochet B, Quesson B, et al. In vivo evaluation of remyelination in rat brain by magnetization transfer imaging. J Neurol Sci. 2000;178:10–16.
   PubMed Web of Science ®Google Scholar
• Chen JT, Kuhlmann T, Jansen GH, et al. Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion. NeuroImage. 2007;36:1152–1158.
   PubMed Web of Science ®Google Scholar
• Fox RJ, Beall E, Bhattacharyya P, et al. Advanced MRI in multiple sclerosis: current status and future challenges. Neurol Clin. 2011;29:357–380.
   PubMed Web of Science ®Google Scholar
• Stankoff B, Wang Y, Bottlaender M, et al. Imaging of CNS myelin by positron-emission tomography. Proc Natl Acad Sci. 2006;103:9304–9309.
   PubMed Web of Science ®Google Scholar
• Stankoff B, Freeman L, Aigrot M-S, et al. Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-11C]-2-(4-methylaminophenyl)6hydroxybenzothiazole. Ann Neurol. 2011;69:673–680.
   PubMed Web of Science ®Google Scholar
• Iaccarino L, Chiotis K, Alongi P, et al. A cross-validation of FDG and Amyloid-PET biomarkers in mild cognitive impairment for the risk prediction to dementia due to Alzheimer’s disease in a clinical setting. J Alzheimers Dis. 2017;59:603–614.
   PubMed Web of Science ®Google Scholar
• Flynn SW, Lang DJ, Mackay AL, et al. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol Psychiatry. 2003;8:811–820.
   PubMed Web of Science ®Google Scholar
• Ettle B, Schlachetzki JC, Winkler J. Oligodendroglia and myelin in neurodegenerative diseases: more than just bystanders? Mol Neurobiol. 2016;53:3046–3062.
   PubMed Web of Science ®Google Scholar
• Windrem MS, Osipovitch M, Liu Z, et al. Human iPSC glial mouse chimeras reveal glial contributions to schizophrenia. Cell Stem Cell. 2017;21:195–208e6.
   PubMed Web of Science ®Google Scholar
• Kang SH, Li Y, Fukaya M, et al. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci. 2013;16:571–579.
   PubMed Web of Science ®Google Scholar
• Benraiss A, Wang S, Herrlinger S, et al. Human glia can both induce and rescue aspects of disease phenotype in Huntington disease. Nat Commun. 2016;7:11758.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhou J. Oligodendrocytes in neurodegenerative diseases. Front Biol. 2013;8:127–133.
   Google Scholar